ERBB RECEPTOR CONTROL OF BREAST CANCER GROWTH

ERBB 受体控制乳腺癌生长

基本信息

  • 批准号:
    2896238
  • 负责人:
  • 金额:
    $ 22.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 2001-09-29
  • 项目状态:
    已结题

项目摘要

A crucial role for Epidermal Growth Factor Receptor (erbB) family members in development of breast cancer has been demonstrated over the past 15 years. We have recently cloned a novel protein, EBP1, which interacts with the cytoplasmic domain of erbB3. Treatment of cells with the erbB-3 ligand, heregulin (HRG) induces the translocation of EBP1 from the cytoplasm to the nucleus. Overexpression of EBP1 inhibits proliferation of human breast cancer cells. We propose to study the physiological function of erbB-3EBP1 interactions in human breast cancer cells. Understanding the regulation and consequences of these interactions could lead to a better understanding of erbB-3 signal transduction and to the definition of new therapeutic targets in breast cancer. First, to define the function of erbB-3-EBP1 interactions, we will a) determine HRG-mediated interactions of EBP1 with other erbB receptors and the dependence of such interactions on the expression of erbB-3 heterodimeric binding partners using the yeast-two hybrid system and engineered murine cells expressing defined combinations of erbB receptors 2) establish the colocalization of EBP1 and erbB-3 by confocal microscopy before and after HRG treatment, c) determine the region of EBP1 required for erbB-3 binding and the effects of expression of different regions of EBP1 on HRG-mediated signalling using a series of deletion and single site mutants of EBP1, d) determine the effects of EBP1 overexpression on basal and HRG-induced cell growth and differentiation using stable transfectants with inducible expression. Second, we will determine the role of Protein Kinase C (PKC) in modulating EBP1 activity. The sites of phosphorylation after HRG treatment will be determined using tryptic phosphopeptide mapping and phosphamino acid analysis. Effects of PKC inhibitors on EBP1 function will be assessed in intact cells. Potential PKC sites will be mutated and effects of such mutations on EBP1 function defined. Third, we will define the significance of EBP1 nuclear localization. We will a) determine if EBP1 is part of a multiprotein nuclear localization complex by isolating EBP1 interacting proteins using the yeast two-hybrid system b) define the role of EBP1 and its accessory transcriptional activators using GAL4 DNA binding domain fusions c) identify preferred DNA binding sites for EBP1 using a degenerate oligonucleotide strategy.
表皮生长因子受体(erbB)家族的重要作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNE W. HAMBURGER其他文献

ANNE W. HAMBURGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNE W. HAMBURGER', 18)}}的其他基金

A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
HRPC 中雄激素受体水平控制的新机制
  • 批准号:
    8260550
  • 财政年份:
    2011
  • 资助金额:
    $ 22.74万
  • 项目类别:
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
HRPC 中雄激素受体水平控制的新机制
  • 批准号:
    8038769
  • 财政年份:
    2011
  • 资助金额:
    $ 22.74万
  • 项目类别:
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
HRPC 中雄激素受体水平控制的新机制
  • 批准号:
    8447576
  • 财政年份:
    2011
  • 资助金额:
    $ 22.74万
  • 项目类别:
A novel therapy for HER2 positive hormone refractory breast cancer
HER2阳性激素难治性乳腺癌的新疗法
  • 批准号:
    7943990
  • 财政年份:
    2009
  • 资助金额:
    $ 22.74万
  • 项目类别:
A novel therapy for HER2 positive hormone refractory breast cancer
HER2阳性激素难治性乳腺癌的新疗法
  • 批准号:
    7814609
  • 财政年份:
    2009
  • 资助金额:
    $ 22.74万
  • 项目类别:
EBP1 CONTROL OF PROSTATE CANCER CELL GROWTH
EBP1 控制前列腺癌细胞生长
  • 批准号:
    6498063
  • 财政年份:
    2001
  • 资助金额:
    $ 22.74万
  • 项目类别:
EBP1 CONTROL OF PROSTATE CANCER CELL GROWTH
EBP1 控制前列腺癌细胞生长
  • 批准号:
    6225303
  • 财政年份:
    2001
  • 资助金额:
    $ 22.74万
  • 项目类别:
ERBB RECEPTOR CONTROL OF BREAST CANCER GROWTH
ERBB 受体控制乳腺癌生长
  • 批准号:
    2698169
  • 财政年份:
    1998
  • 资助金额:
    $ 22.74万
  • 项目类别:
ErbB Receptor Control of Breast Cancer Growth
ErbB 受体控制乳腺癌生长
  • 批准号:
    7089943
  • 财政年份:
    1998
  • 资助金额:
    $ 22.74万
  • 项目类别:
ErbB Receptor Control of Breast Cancer Growth
ErbB 受体控制乳腺癌生长
  • 批准号:
    6623756
  • 财政年份:
    1998
  • 资助金额:
    $ 22.74万
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    $ 22.74万
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    $ 22.74万
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    $ 22.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了